genetic engineering Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't' Premium Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics. Ginkgo Bioworks Launches $350M Funding Vehicle for Spinoffs Ginkgo plans to strategically partner with leading companies in mature markets to create synthetic biology-based spinouts, something it has already done in ag-bio. Ginkgo Bioworks Raises $290M in Series E Financing The Boston-based synthetic biology firm said it will use the funds to grow its cell programing platform, which it will make available to startups. Sherlock Biosciences Closes $31M Series A Financing Round The company launched last month with initial financing of $35 million and licenses to CRISPR and synthetic biology technology from the Broad and Harvard. Q&A: Andreessen Horowitz's Jorge Conde Discusses Power of Meshing Biology and Engineering Premium The former cofounder of Knome believes that the future of precision medicine lies in our ability to program living things to act as medicines. Aug 31, 2017 Cowen Initiates Coverage of Horizon Discovery at Outperform Feb 16, 2017 NAS Human Genome Editing Report Braces for Germline Modifications Premium Feb 3, 2017 IDT Adds New CRISPR System to Commercial Genome Editing Toolbox Premium Jan 20, 2017 ExxonMobil, Synthetic Genomics Renew Biofuels Research Collaboration Apr 25, 2011 Intrexon Raises $66.9M May 1, 2009 In Brief This Week: GeneNews; Fluidigm; MDS, Promega; AnaSpec Mar 25, 2009 Gene Bridges Inks License with Japanese Pharma Firm Mar 17, 2009 Short Reads: Mar 17, 2009 Premium Feb 27, 2009 The World of DIY Bio Premium Feb 15, 2009 At AAAS, Drew Endy Calls for US Synthetic Biology Initiative Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.